FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to compounds and pharmaceutical compositions for treating infectious diseases of the oral cavity. Disclosed is a compound of formula IX, or its enantiomers or stereoisomers. Also disclosed is a pharmaceutical composition containing an effective amount of the declared compound and a pharmaceutically acceptable carrier.
(IX).
EFFECT: group of inventions provides obtaining compounds for preventing and/or treating fungal infections, candidiasis or infectious diseases of the oral cavity.
4 cl, 10 dwg, 1 ex
Authors
Dates
2022-04-14—Published
2017-04-19—Filed